Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|April 1, 1996
Phase II trial of hydroxyurea, dacarbazine (DTIC), and etoposide (VP-16) in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group studyJ L Currie, J A Blessing, R McGehee, et al.
Gynecologic Oncology|June 1, 1983
Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group studyF B Stehman, J Blom, J A Blessing, et al.
American Journal of Clinical Oncology|February 1, 1990
Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology groupR F Asbury, J A Blessing, W P McGuire, et al.
Investigational New Drugs|November 1, 1989
Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group studyG P Sutton, J A Blessing, L Adcock, et al.
Gynecologic Oncology|December 1, 1990
Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: a Gynecologic Oncology Group studyH D Homesley, J A Blessing, J Schlaerth, et al.
Gynecologic Oncology|June 1, 1995
Phase II trial of mitomycin-C in squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group studyT Thigpen, J A Blessing, D G Gallup, et al.
Gynecologic Oncology|April 1, 1989
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, H Homesley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group studyW P McGuire, J A Blessing, D Moore, et al.
American Journal of Obstetrics and Gynecology|August 1, 1989
Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study)G P Sutton, J A Blessing, N Rosenshein, et al.
American Journal of Clinical Oncology|August 1, 1987
Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology GroupR F Asbury, J A Blessing, R Mortel, et al.
Pageof 18